IPP Bureau
USFDA issues Form 483 for Parawada unit of Laurus Labs
By IPP Bureau - October 30, 2022
The observation is procedural in nature and the company will address the observation within stipulated timelines.
Madhur Gundecha appointed CFO of Astec Lifesciences
By IPP Bureau - October 30, 2022
He has over 23 years' experience working in leading companies such as Omniactive Health Technologies, Johnson Matthey Chemicals, BASF, Godrej Agrovet Limited & Bharat Petroleum Corporation Limited.
21.4 lakh TB cases notified in India in 2021
By IPP Bureau - October 30, 2022
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
Recent launch of 5G will bring a new revolution in digital healthcare: Dr. Singh
By IPP Bureau - October 30, 2022
India will become a digital health leader, as we have the world’s best technical manpower required and our data is the cheapest in the world, approaching 100 percent coverage
Granules India plans H2 FY 2022-23 R&D spend in Rs. 80-90 Cr
By IPP Bureau - October 30, 2022
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
Mandaviya addresses Second G20 Health Ministers Meet
By IPP Bureau - October 28, 2022
He also encouraged all G20 members to contribute their public keys to the proposed Global Federated Public Trust Directory for ensuring seamless worldwide mobility of people and goods
Centre deploys high-level team to Kerala to investigate Avian Influenza Outbreak
By IPP Bureau - October 28, 2022
The team will also assist the state health departments in terms of public health measures, management guidelines and protocols to manage the increasing cases of Avian Influenza
Vimta Labs posts consolidated PAT of Rs. 13.21 crores in Q2FY23
By IPP Bureau - October 28, 2022
The company has posted net profit of Rs. 13.21 crores for the period ended September 30, 2022
ProBioGen co-develops new Freedom ExpiCHO-S cell line development kit
By IPP Bureau - October 28, 2022
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset
By IPP Bureau - October 28, 2022
The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cell imaging data set
Gland Pharma’s Q2 FY23 revenue stood at Rs. 1,044.4 Cr
By IPP Bureau - October 27, 2022
Gland Pharma Q2 FY2023 consolidated net profit up at Rs. 241.24 Cr
Dabur India posts consolidated Q2 FY2023 PAT at Rs. 490.06 Cr
By IPP Bureau - October 27, 2022
The company has reported total income of Rs. 3109.77 crores during the period ended September 30, 2022
Zydus gets USFDA’s approval for Ketorolac Tromethamine Tablets
By IPP Bureau - October 27, 2022
Ketorolac Tromethamine Tablets are indicated to relieve moderately severe pain, usually after surgery.
USFDA Issues a CRL for the Biologics License Application for Insulin Aspart
By IPP Bureau - October 27, 2022
The CRL did not identify any outstanding scientific issues with the product.
Camizestrant significantly improved PFS vs. Faslodex in SERENA-2 Phase II trial
By IPP Bureau - October 27, 2022
Results reinforce commitment to next-generation oral SERD development programme
